Faroalfa-ER Tablet
By Faroalfa
Rx
4 Tablet ER in a Strip

Composition
Faropenem(300mg)

Manufacturer - Alniche Life Sciences Pvt Ltd
Alniche Life Sciences Pvt. Ltd., S-14, 2nd Floor, Janta Market Rajouri Garden, New Delhi – 110 027

Expires on or after
June, 2026

liver
The safety of using Faroalfa-ER Tablet in patients with liver disease is not well studied. It is advisable to consult your doctor before taking this medication if you have liver issues. Prior medical advice is crucial to ensure the safe use of Faroalfa-ER Tablet in individuals with liver conditions.

kidney
Limited information on using Faroalfa-ER Tablet in kidney disease patients. Consult your doctor for guidance.

alcohol
It is safe to consume alcohol with Faroalfa-ER Tablet as it does not cause any harmful side effects.

driving
When taking Faroalfa-ER Tablet, refrain from driving if you have symptoms affecting concentration and reaction time. The impact on driving ability is unknown.

pregnancy
Faroalfa-ER Tablet is not recommended during pregnancy as studies have shown potential harmful effects on the developing baby in animal studies. Please consult your doctor for further guidance.

breastfeeding
Faroalfa-ER Tablet is deemed safe for breastfeeding based on limited human data indicating no notable risk to the baby.
Habit Forming | No |
Chemical Class | Alpha Amino Acids Derivatives |
Therapeutic Class | ANTI INFECTIVES |
Action Class | Penem |
₹360
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024